Profile data is unavailable for this security.
About the company
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
- Revenue in CHF (TTM)8.59bn
- Net income in CHF941.84m
- Incorporated2018
- Employees25.32k
- LocationAlcon AGRue Louis d'Affry 6FRIBOURG 1701SwitzerlandCHE
- Websitehttps://www.alcon.ch/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demant A/S | 2.92bn | 332.31m | 8.69bn | 21.62k | 26.39 | 7.19 | -- | 2.97 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
| Smith & Nephew plc | 5.03bn | 238.54m | 9.78bn | 18.45k | 40.94 | 2.06 | 11.40 | 1.94 | 0.2383 | 0.2383 | 5.03 | 4.73 | 0.5562 | 0.7522 | 4.33 | 237,877.40 | 2.64 | 4.10 | 3.29 | 4.99 | 68.82 | 71.39 | 4.74 | 8.02 | 0.72 | 4.84 | 0.3715 | 79.59 | 6.40 | 2.50 | 17.94 | -16.88 | 4.24 | 1.85 |
| BioMerieux SA | 3.57bn | 347.33m | 10.31bn | 14.65k | 29.81 | 2.82 | 17.23 | 2.89 | 3.01 | 3.01 | 30.93 | 31.76 | 0.7036 | 1.97 | 5.00 | 250,815.60 | 6.18 | 9.30 | 7.88 | 12.31 | 55.99 | 56.51 | 8.78 | 12.38 | 1.19 | -- | 0.1215 | 17.76 | 2.39 | 8.70 | -20.95 | 6.87 | 8.36 | 19.42 |
| Sartorius Stedim Biotech SA | 2.64bn | 247.39m | 13.87bn | 10.60k | 53.71 | 3.53 | 27.61 | 5.26 | 2.73 | 2.73 | 29.11 | 41.57 | 0.4013 | 1.60 | 7.82 | 254,764.60 | 3.81 | 11.87 | 4.55 | 15.12 | 42.98 | 50.96 | 9.49 | 17.44 | 1.24 | 6.59 | 0.452 | 18.73 | -20.53 | 18.02 | -64.65 | 8.28 | 21.82 | 3.90 |
| Sartorius AG | 3.22bn | 144.43m | 13.98bn | 14.34k | 79.20 | 4.42 | 24.63 | 4.34 | 2.18 | 2.18 | 48.85 | 39.05 | 0.3765 | 1.62 | 7.83 | 226,638.80 | 2.51 | 8.21 | 3.43 | 11.83 | 45.11 | 50.93 | 6.65 | 14.15 | 1.28 | 3.41 | 0.5804 | 19.59 | -18.66 | 16.74 | -69.74 | 7.74 | 19.14 | 3.66 |
| Sonova Holding AG | 3.63bn | 601.00m | 16.71bn | 18.15k | 27.90 | 6.76 | 19.53 | 4.61 | 10.05 | 10.05 | 60.66 | 41.44 | 0.6394 | 2.35 | 6.82 | 199,818.20 | 10.75 | 10.87 | 13.45 | 13.88 | 72.28 | 71.97 | 16.80 | 17.77 | 1.07 | 31.44 | 0.4268 | 35.21 | -2.98 | 5.59 | -5.84 | 5.77 | 1.75 | 8.20 |
| Straumann Holding AG | 2.41bn | 246.07m | 17.97bn | 11.11k | 73.11 | 9.79 | 47.66 | 7.45 | 1.54 | 1.54 | 15.11 | 11.52 | 0.7204 | 1.81 | 4.29 | 217,105.00 | 7.37 | 10.68 | 9.86 | 13.63 | 74.15 | 74.95 | 10.23 | 15.15 | 1.43 | 6.72 | 0.1968 | 37.50 | 3.92 | 12.08 | -43.40 | -2.04 | 11.54 | 10.12 |
| Koninklijke Philips NV | 17.62bn | -770.23m | 21.41bn | 69.06k | -- | -- | 73.72 | 1.22 | -0.8365 | -0.8437 | 18.87 | -- | -- | -- | -- | 260,437.00 | -- | 0.3678 | -- | 0.5013 | 41.39 | 43.84 | -4.35 | 0.6049 | -- | 5.77 | -- | -- | 1.92 | 0.0529 | 71.87 | -- | -5.24 | -- |
| Coloplast A/S | 3.32bn | 646.52m | 22.78bn | 15.93k | 36.87 | 11.55 | 28.53 | 6.85 | 22.57 | 22.57 | 115.97 | 72.05 | 0.5941 | 2.37 | 5.92 | 1,626,689.00 | 11.56 | 20.45 | 16.78 | 29.69 | 67.13 | 67.91 | 19.45 | 21.73 | 0.3946 | 11.85 | 0.602 | 91.08 | 8.51 | 8.29 | 1.64 | 4.46 | 13.15 | 5.59 |
| Alcon AG | 8.59bn | 941.84m | 40.07bn | 25.32k | 42.28 | 2.12 | 19.67 | 4.66 | 1.90 | 1.90 | 17.31 | 37.86 | 0.3249 | 1.86 | 5.33 | 339,457.60 | 3.56 | 0.3538 | 3.88 | 0.3866 | 55.74 | 52.71 | 10.96 | 1.22 | 1.49 | 6.66 | 0.1963 | 81.12 | 8.47 | 5.74 | 190.75 | -- | 3.68 | -- |
| Siemens Healthineers AG | 21.24bn | 1.79bn | 58.99bn | 71.80k | 32.81 | 3.23 | 19.50 | 2.78 | 1.64 | 1.64 | 19.51 | 16.66 | 0.4772 | 3.09 | 3.86 | 308,000.00 | 4.05 | 4.88 | 5.54 | 6.60 | 37.50 | 37.82 | 8.48 | 9.22 | 0.8869 | 21.67 | 0.4669 | 54.89 | -0.1566 | 10.05 | -25.96 | 3.59 | 9.60 | 18.98 |
| EssilorLuxottica SA | 24.67bn | 2.22bn | 89.64bn | 191.71k | 39.71 | 2.39 | 17.18 | 3.63 | 5.08 | 5.08 | 56.34 | 84.59 | 0.4195 | 3.46 | 9.02 | 132,468.50 | 4.01 | 2.73 | 4.80 | 3.21 | 62.22 | 61.28 | 9.55 | 7.52 | 0.7156 | 42.29 | 0.2306 | 75.45 | 3.68 | 18.58 | 6.37 | 16.15 | 16.61 | 14.13 |
